BioCentury
ARTICLE | Clinical News

BrachySeed palladium-103 brachytherapy seed regulatory update

November 19, 2001 8:00 AM UTC

DRAX subsidiary Draximage Inc. received approval from the U.S. Nuclear Regulatory Commission (NRC) for the palladium (Pd) version of its BrachySeed radioactive brachytherapy implant. DRAX said the NRC...